(Q39374052)

11 September 2017

title

Effectiveness and safety of oral extended-release oxymorphone for the treatment of cancer pain: a pilot study (English)

1 reference

11 September 2017

1 reference

Paul Sloan

1

1 reference

11 September 2017

Neal Slatkin

series ordinal

2

1 reference

11 September 2017

Harry Ahdieh

series ordinal

3

1 reference

11 September 2017

language of work or name

1 reference

9 November 2004

1 reference

Supportive Care in Cancer

11 September 2017

published in

1 reference

11 September 2017

volume

13

1 reference

11 September 2017

issue

1

1 reference

11 September 2017

page(s)

57-65

1 reference

Cancer pain relief and palliative care. Report of a WHO Expert Committee

11 September 2017

cites work

1 reference

12 December 2020

Analgesic efficacy and safety of two oral controlled-release morphine preparations in orthopedic postoperative pain.

1 reference

12 December 2020

Pharmacokinetic Modeling of M6G Formation after Oral Administration of Morphine in Healthy Volunteers

1 reference

12 December 2020

Day-to-day titration to initiate transdermal fentanyl in patients with cancer pain: short- and long-term experiences in a prospective study of 39 patients.

1 reference

12 December 2020

The efficacy and safety of oral immediate-release oxymorphone for postsurgical pain

1 reference

12 December 2020

Plasma concentrations of morphine, morphine-6-glucuronide and morphine-3-glucuronide and their relationship with analgesia and side effects in patients with cancer-related pain

1 reference

12 December 2020

Randomized, double-blind, cross-over trial comparing safety and efficacy of oral controlled-release oxycodone with controlled-release morphine in patients with cancer pain

1 reference

12 December 2020

The analgesic equivalence to morphine and relative side action liability of oxymorphone (14-hydroxydihydro morphinone)

1 reference

12 December 2020

Pharmacogenetics affects dosing, efficacy, and toxicity of cytochrome P450-metabolized drugs

1 reference

12 December 2020

Placebo-blinded study of morphine sulfate sustained-release tablets and immediate-release morphine sulfate solution in outpatients with chronic pain due to advanced cancer

1 reference

12 December 2020

Pharmacokinetics and clinical efficacy of oral morphine solution and controlled-release morphine tablets in cancer patients

1 reference

12 December 2020

Single nucleotide polymorphisms in the human mu opioid receptor gene alter basal G protein coupling and calmodulin binding

1 reference

12 December 2020

The intrinsic antinociceptive effects of oxycodone appear to be kappa-opioid receptor mediated

1 reference

12 December 2020

Dose ratio between morphine and methadone in patients with cancer pain: a retrospective study

1 reference

12 December 2020

Practice guidelines for cancer pain management. A report by the American Society of Anesthesiologists Task Force on Pain Management, Cancer Pain Section

1 reference

12 December 2020

Effects of blocking CYP2D6 on the pharmacokinetics and pharmacodynamics of oxycodone.

1 reference

12 December 2020

The mu opiate receptor as a candidate gene for pain: polymorphisms, variations in expression, nociception, and opiate responses

1 reference

12 December 2020

Bedside perspectives on the use of opioids: transferring results of clinical research into practice

1 reference

12 December 2020

Opioid pharmacotherapy in the management of cancer pain: a survey of strategies used by pain physicians for the selection of analgesic drugs and routes of administration

1 reference

12 December 2020

Comparisons of the Analgesic Effects of Oral and Intramuscular Oxymorphone and of Intramuscular Oxymorphone and Morphine in Patients with Cancer

1 reference

12 December 2020

A clinical evaluation of transdermal therapeutic system fentanyl for the treatment of cancer pain

1 reference

12 December 2020

Opioid rotation in the management of refractory cancer pain

1 reference

12 December 2020

Comparative clinical efficacy and safety of a novel controlled-release oxycodone formulation and controlled-release hydromorphone in the treatment of cancer pain

1 reference

12 December 2020

Toxicity and/or insufficient analgesia by opioid therapy: risk factors and the impact of changing the opioid. A retrospective analysis of 273 patients observed at a single center

1 reference

12 December 2020

Investigation of the selectivity of oxymorphone- and naltrexone-derived ligands via site-directed mutagenesis of opioid receptors: exploring the "address" recognition locus

1 reference

12 December 2020

Quantitative contribution of CYP2D6 and CYP3A to oxycodone metabolism in human liver and intestinal microsomes

1 reference

12 December 2020

Oxymorphone--Endo/Penwest: EN 3202, EN 3203

1 reference

12 December 2020

Pharmacology and mechanisms of opioid analgesic activity

1 reference

12 December 2020

Controlled-release oxycodone and morphine in cancer related pain.

1 reference

12 December 2020

Relative potency of controlled-release oxycodone and controlled-release morphine in a postoperative pain model

1 reference

12 December 2020

A randomized, double-blind, double-dummy, crossover trial comparing the safety and efficacy of oral sustained-release hydromorphone with immediate-release hydromorphone in patients with cancer pain. Canadian Palliative Care Clinical Trials Group

1 reference

12 December 2020

Oxymorphone metabolism and urinary excretion in human, rat, guinea pig, rabbit, and dog

1 reference

12 December 2020

Randomized evaluation of controlled-release codeine and placebo in chronic cancer pain

1 reference

12 December 2020

Sequence variability and candidate gene analysis in complex disease: association of mu opioid receptor gene variation with substance dependence

1 reference

12 December 2020

Long-term patterns of morphine dosage and pain intensity among cancer patients

1 reference

12 December 2020

A single nucleotide polymorphic mutation in the human mu-opioid receptor severely impairs receptor signaling

1 reference

12 December 2020

Long-term administration of controlled-release oxycodone tablets for the treatment of cancer pain

1 reference

12 December 2020

Responsible prescribing of opioids for the management of chronic pain

1 reference

12 December 2020

Morphine or oxycodone in cancer pain?

1 reference

12 December 2020

Pharmacotherapy of cancer-related episodic pain

1 reference

12 December 2020

Opioids in pain management

1 reference

12 December 2020

Efficacy of oxymorphone extended release in postsurgical pain: a randomized clinical trial in knee arthroplasty

1 reference

12 December 2020

10.1007/S00520-004-0731-1

Identifiers

DOI

1 reference

11 September 2017

1 reference